Skip to main content
Have a personal or library account? Click to login
Type 1 Diabetes in the Young: Organization of two National Centers in Israel and Slovenia / Sladkorna Bolezen Tipa 1 Pri Otrocih in Mladostnikih: Organizacija Dela V Dveh Nacionalnih Centrih V Izraelu in Sloveniji Cover

Type 1 Diabetes in the Young: Organization of two National Centers in Israel and Slovenia / Sladkorna Bolezen Tipa 1 Pri Otrocih in Mladostnikih: Organizacija Dela V Dveh Nacionalnih Centrih V Izraelu in Sloveniji

Slovenian Journal of Public Health
Volume 54 (2015): Issue 2 (June 2015)
By: ,  ,   and    
Open Access
|Mar 2015
References

References

  1. 1. Bratina NU, Tahirović H, Battelino T, Krzisnik C. Incidence of childhoodonset Type I diabetes in Slovenia and the Tuzia region (Bosnia and Herzegovina) in the period 1990-1998. Diabetologia 2001; 44(Suppl 3): B27-31.
    Open DOISearch in Google Scholar
  2. 2. Patterson CC, Gyürüs E, Rosenbauer J, Cinek O, Neu A. et al. Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia 2012; 55: 2142-7.
    Open DOISearch in Google Scholar
  3. 3. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009; 373: 2027-33.
    Open DOISearch in Google Scholar
  4. 4. Radosevic B, Bukara-Radujkovic G, Miljkovic V, Pejicic S, Bratina N, Battelino T. The incidence of type 1 diabetes in Republic of Srpska (Bosnia and Herzegovina) and Slovenia in the period 1998-2010. Pediatr Diabetes 2013; 14: 273-9.
    Open DOISearch in Google Scholar
  5. 5. Blumenfeld O, Dichtiar R, Shohat T, Israel IDDM Registry Study Group (IIRSG). Trends in the incidence of type 1 diabetes among Jews and Arabs in Israel. Pediatr Diabetes 2014; 15: 422-7.
    Open DOISearch in Google Scholar
  6. 6. Vehik K, Hamman RF, Lezotte D, Norris JM, Klingensmith GJ, Dabelea D. Childhood growth and age at diagnosis with Type 1 diabetes in Colorado young people. Diabet Med 2009; 26: 961-7.
    Open DOISearch in Google Scholar
  7. 7. Ehehalt S, Dietz K, Willasch AM, Neu A, DIARY-Group Baden- Wuerttemberg. Prediction model for the incidence and prevalence of type 1 diabetes in childhood and adolescence: evidence for a cohortdependent increase within the next two decades in Germany. Pediatr Diabetes 2012; 13: 15-20.
    Open DOISearch in Google Scholar
  8. 8. Krasevec A. Newly discovered diabetes in children and adolescent in Slovenia: review and analyses of epidemiological and clinical data: master degree thesis. Ljubljana: Visoka šola za zdravstvo, 2013: 1-33.
    Search in Google Scholar
  9. 9. Laron Z, Galatzer A, Amir S, Gil R, Karp M, Mimouni M. A multidisciplinary, comprehensive, ambulatory treatment scheme for diabetes mellitus in children. Diabetes Care 1979; 2: 342-8.
    Open DOISearch in Google Scholar
  10. 10. Kržišnik C, Bratanič N, Brus L. The current treatment of children and adolescents with insulin dependent diabetes in Slovenia. Zdrav Vest 1990; 59: 67-9.
    Search in Google Scholar
  11. 11. Matajc L. Diabetes mellitus infantilis et juvenilis . Sladkorčki 1979: 1-49.
    Search in Google Scholar
  12. 12. DCCT Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: the diabetes control and complications trial. J Pediatr 1994; 125: 177-88.
    Open DOISearch in Google Scholar
  13. 13. Danne T, Bangstad HJ, Deeb L, Jarosz-Chobot P, Mungaie L, Saboo B. et al. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes 2014; 15(Suppl 20): 115-34.
    Open DOISearch in Google Scholar
  14. 14. Holl RW, Swift PG, Mortensen HB, Lynggaard H, Hougaard P, Aanstoot HJ. et al. Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study group. Eur J Pediatr 2003; 162: 22-9.
    Open DOISearch in Google Scholar
  15. 15. Pihoker C, Badaru A, Anderson A, Morgan T, Dolan L, Dabelea D. et al. Insulin regimens and clinical outcomes in a type 1 diabetes cohort: the search for diabetes in youth study. Diabetes Care 2013; 36: 27-33.
    Open DOISearch in Google Scholar
  16. 16. Shalitin S, Ben-Ari T, Yackobovitch-Gavan M, Tenenbaum A, Lebenthal Y, de Vries L. et al. Using the internet-based upload blood glucose monitoring and therapy management system in patients with type 1 diabetes. Acta Diabetol 2014; 51: 247-56.
    Open DOISearch in Google Scholar
  17. 17. Smart CE, Annan F, Bruno LP, Higgins LA, Acerini CL. Nutritional management in children and adolescents with diabetes. Pediatr Diabetes 2014; 15(Suppl 20): 135-53.
    Open DOISearch in Google Scholar
  18. 18. Hoey H, Hvidoere Study Group on Childhood Diabetes. Psychosocial factors are associated with metabolic control in adolescents: research from the Hvidoere Study Group on Childhood Diabetes. Pediatr Diabetes 2009; 10(Suppl 13): 9-14.
    Open DOISearch in Google Scholar
  19. 19. Shorer M, David R, Schoenberg-Taz M, Levavi-Lavi I, Phillip M, Meyerovitch J. Role of parenting style in achieving metabolic control in adolescents with type 1 diabetes. Diabetes Care 2011; 34: 1735-7.
    Open DOISearch in Google Scholar
  20. 20. Wigert H, Wikström E. Organizing person-centred care in paediatric diabetes: multidisciplinary teams, long-term relationships and adequate documentation. BMC Res Notes 2014; 7: 72.
    Open DOISearch in Google Scholar
  21. 21. Shalitin S, Gil M, Nimri R, de Vries L, Gavan MY, Phillip M. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy. Diabet Med 2010; 27: 339-47.
    Open DOISearch in Google Scholar
  22. 22. Wolfsdorf JI, Allgrove J, Craig ME, Edge J, Glaser N, Jain V. et al. Diabetic ketoacidosis and hyperglycemic hypersmolar state. Pediatric Diabetes 2014; 15(Suppl 20): 154-79.
    Open DOISearch in Google Scholar
  23. 23. Ly TT, Maahs DM, Rewers A, Dunger D, Oduwole A, Jones TW. Assessment and management of Hypoglycemia. Pediatric Diabetes 2014; 15(Suppl 20): 180-92.
    Open DOISearch in Google Scholar
  24. 24. Dovc K, Telic SS, Lusa L, Bratanic N, Zerjav-Tansek M, Kotnik P. et al. Improved metabolic control in pediatric patients with type 1 diabetes: a nationwide prospective 12-year time trends analysis. Diabetes Technol Ther 2014; 16: 33-40.
    Open DOISearch in Google Scholar
  25. 25. Swift PG. Diabetes education in children and adolescents. Pediatr Diabetes 2009; 10(Suppl 12): 51-7.
    Open DOISearch in Google Scholar
  26. 26. Bratina N, Battelino T. Insulin pumps and continuous glucose monitoring (CGM) in preschool and school-age children: how schools can integrate technology. Pediatr Endocrinol Rev 2010; 7(Suppl 3): 417-21.
    Search in Google Scholar
  27. 27. Shalitin S, Lahav-Ritte T, Lebenthal Y, Devries L, Phillip M. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control? Diabetes Technol Ther 2012; 14: 389-97.
    Search in Google Scholar
  28. 28. Tamborlane WV, Fredrickson LP, Ahern JH. Insulin pump therapy in childhood diabetes mellitus: guidelines for use. Treat Endocrinol 2003; 2: 11-21.
    Open DOISearch in Google Scholar
  29. 29. de Vries L, Grushka Y, Lebenthal Y, Shalitin S, Phillip M. Factors associated with increased risk of insulin pump discontinuation in pediatric patients with type 1 diabetes. Pediatr Diabetes 2011; 12: 506-12.
    Open DOISearch in Google Scholar
  30. 30. Phillip M, Danne T, Shalitin S, Buckingham B, Laffel L, Battelino T. et al. Use of continuous glucose monitoring in children and adolescents. Pediatr Diabetes 2012; 13: 215-28.
    Open DOISearch in Google Scholar
  31. 31. Nørgaard K, Scaramuzza A, Bratina N, Lalić NM, Jarosz-Chobot P, Kocsis G. et al. Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study. Diabetes Technol Ther 2013; 15: 273-80.
    Open DOISearch in Google Scholar
  32. 32. Shalitin S, Phillip M. Hypoglycemia in type 1 diabetes: a still unresolved problem in the era of insulin analogs and pump therapy. Diabetes Care 2008; 31(Suppl 2): S121-4.
    Open DOISearch in Google Scholar
  33. 33. Battelino T, Bolinder J. Clinical use of real-time continuous glucose monitoring. Curr Diabetes Rev 2008; 4: 218-22.
    Open DOISearch in Google Scholar
  34. 34. Battelino T, Conget I, Olsen B, Schütz-Fuhrmann I, Hommel E, Hoogma R. et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 2012; 55: 3155-62.
    Open DOISearch in Google Scholar
  35. 35. Battelino T, Phillip M. Real-time continuous glucose monitoring in randomized control trials. Pediatr Endocrinol Rev 2010; 7(Suppl 3): 401-4.
    Search in Google Scholar
  36. 36. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011; 34: 795-800.
    Open DOISearch in Google Scholar
  37. 37. Hommel E, Olsen B, Battelino T, Conget I, Schütz-Fuhrmann I, Hoogma R. et al. Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study. Acta Diabetol 2014; 51: 845-51.
    Open DOISearch in Google Scholar
  38. 38. Bode BW, Battelino T. Continuous glucose monitoring in 2012. Diabetes Technol Ther 2013; 15(Suppl 1): S13-23.
    Open DOISearch in Google Scholar
  39. 39. Battelino T, Bode BW. Continuous glucose monitoring in 2013. Diabetes Technol Ther 2014; 16(Suppl 1): S11-6.
    Open DOISearch in Google Scholar
  40. 40. Ludvigsson J, Krisky D, Casas R, Battelino T, Castaño L, Greening J. et al. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. N Engl J Med 2012; 366: 433-42.
    Open DOISearch in Google Scholar
  41. 41. Nimri R, Lebenthal Y, Shalitin S, Benzaquen H, Demol S, Phillip M. Metabolic control by insulin detemir in basal-bolus therapy: treat-totarget study in children and adolescents with type 1 diabetes. Pediatr Diabetes 2013; 14: 196-202.
    Search in Google Scholar
  42. 42. Klein DJ, Battelino T, Chatterjee DJ, Jacobsen LV, Hale PM, Arslanian S. et al. Liraglutide’s safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Technol Ther 2014; 16: 679-87.
    Open DOISearch in Google Scholar
  43. 43. Lebenthal Y, Lazar L, Benzaquen H, Shalitin S, Phillip M. Patient perceptions of using the OmniPod system compared with conventional insulin pumps in young adults with type 1 diabetes. Diabetes Technol Ther 2012; 14: 411-7.
    Open DOISearch in Google Scholar
  44. 44. Buse JB, Kudva YC, Battelino T, Davis SN, Shin J, Welsh JB. Effects of sensor-augmented pump therapy on glycemic variability in wellcontrolled type 1 diabetes in the STAR 3 study. Diabetes Technol Ther 2012; 14: 644-7.
    Open DOISearch in Google Scholar
  45. 45. Adolfsson P, Veijola R, Huot C, Hansen HD, Lademann JB, Phillip M. Safety and patient perception of an insulin pen with simple memory function for children and adolescents with type 1 diabetes--the REMIND study. Curr Med Res Opin 2012; 28: 1455-63.
    Open DOISearch in Google Scholar
  46. 46. Liberman A, Buckingham B, Phillip M. Diabetes technology and the human factor. Int J Clin Pract 2011; (Suppl 170): 83-90.
    Open DOISearch in Google Scholar
  47. 47. Radobuljac MD, Bratina NU, Battelino T, Tomori M. Lifetime prevalence of suicidal and self-injurious behaviors in a representative cohort of Slovenian adolescents with type 1 diabetes. Pediatr Diabetes 2009; 10: 424-31.
    Open DOISearch in Google Scholar
  48. 48. Hovnik T, Dolzan V, Bratina NU, Podkrajsek KT, Battelino T. Genetic polymorphisms in genes encoding antioxidant enzymes are associated with diabetic retinopathy in type 1 diabetes. Diabetes Care 2009; 32: 2258-62.
    Open DOISearch in Google Scholar
  49. 49. Battelino N, Sebestjen M, Keber I, Blagus R, Hovnik T, Bratina N. et al. Endothelial nitric oxide synthase T(-786)C polymorphism in children and adolescents with type 1 diabetes and impaired endotheliumdependent dilatation. Horm Res Paediatr 2011; 76: 248-53.
    Open DOISearch in Google Scholar
  50. 50. Gozlan Y, Tenenbaum A, Shalitin S, Lebenthal Y, Oron T, Cohen O. et al. The glucokinase mutation p.T206P is common among MODY patients of Jewish Ashkenazi descent. Pediatr Diabetes 2012; 13: e14-21.
    Open DOISearch in Google Scholar
  51. 51. Bratanic N, Smigoc Schweiger D, Mendez A, Bratina N, Battelino T, Vidan-Jeras B. An influence of HLA-A, B, DR, DQ, and MICA on the occurrence of Celiac disease in patients with type 1 diabetes. Tissue Antigens 2010; 76: 208-15.
    Open DOISearch in Google Scholar
  52. 52. Smigoc Schweiger D, Mendez A, Kunilo Jamnik S, Bratanic N, Bratina N, Battelino T. et al. Genetic risk for co-occurrence of type 1 diabetes and celiac disease is modified by HLA-C and killer immunoglobulin-like receptors. Tissue Antigens 2014; 84: 471-8.
    Open DOISearch in Google Scholar
  53. 53. Danne T, Lion S, Madaczy L, Veeze H, Raposo F, Rurik I. et al. Criteria for Centers of Reference for pediatric diabetes: an European perspective. Pediatr Diabetes 2012; 13(Suppl 16): 62-75.
    Open DOISearch in Google Scholar
  54. 54. Nimri R, Danne T, Kordonouri O, Atlas E, Bratina N, Biester T. et al. The “Glucositter” overnight automated closed loop system for type 1 diabetes: a randomized crossover trial. Pediatric Diabetes 2013; 14: 159-67.
    Search in Google Scholar
  55. 55. Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S. et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013; 368: 824-33.
    Open DOISearch in Google Scholar
  56. 56. Nimri R, Muller I, Atlas E, Miller S, Fogel A, Bratina N. et al. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial. Diabetes Care 2014; 37: 3025-32.
    Open DOISearch in Google Scholar
  57. 57. Nimri R, Muller I, Atlas E, Miller S, Kordonouri O, Bratina N. et al. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis. Pediatr Diabetes 2014; 15: 91-9.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/sjph-2015-0021 | Journal eISSN: 1854-2476 | Journal ISSN: 0351-0026
Journal RSS Feed
Language: English, Slovenian
Page range: 139 - 145
Submitted on: Nov 5, 2014
Accepted on: Feb 3, 2015
Published on: Mar 13, 2015
Published by: National Institute of Public Health, Slovenia
In partnership with: Paradigm Publishing Services
Keywords:
type 1 diabetes,
children,
metabolic control,
reference centre,
education,
insulin pump,
continuous glucose monitoring
Related subjects:
Medicine,
Clinical medicine,
Hygiene and environmental medicine

© 2015 Nataša Bratina, Shlomit Shalitin, Moshe Phillip, Tadej Battelino, published by National Institute of Public Health, Slovenia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 54 (2015): Issue 2 (June 2015)
Previous article